You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 11, September 15, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Economic and Policy Implications of Early Intervention in HIV Disease

Peter S. Arno, PhD; Douglas Shenson, MD, MPH; Naomi F. Siegel, MSPH; Pat Franks; Philip R. Lee, MD

JAMA. 1989;262(11):1493-1498.


Abstract

Early medical intervention in human immunodeficiency virus disease has farreaching implications for the health care system of the United States. Several factors are enabling the medical community to begin intervention prior to a patient's diagnosis of acquired immunodeficiency syndrome. These factors include an understanding of the biologic markers of disease progression; advances in antiviral therapeutics; and an improved ability to control the most common presenting opportunistic infection, Pneumocystis carinii pneumonia. Providing adequate ambulatory care for large numbers of asymptomatic human immunodeficiency virus—infected individuals and coordinating inner-city health care facilities will become critical. Important questions regarding service provision need to be adequately addressed. The cost of yearly treatment, estimated to be $5 billion per year, will require a major financial commitment at all levels of government and the private sector. Effective early intervention in human immunodeficiency virus disease may alter the course of one of the most devastating epidemics in modern history. Planning for its implementation should begin immediately.

(JAMA. 1989;262:1493-1498)



Author Affiliations

From the Department of Epidemiology and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY (Drs Arno and Shenson); Department of Health Policy and Administration, University of North Carolina, Chapel Hill (Ms Siegel); and the Institute for Health Policy Studies and Center for AIDS Prevention Studies, University of California, San Francisco (Ms Franks and Dr Lee).


Footnotes

Reprint requests to Department of Epidemiology and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467 (Dr Arno).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients
Paltiel and Freedberg
Interfaces 1998;28:34-51.
ABSTRACT  

A Monte Carlo Simulation of Advanced HIV Disease: Application to Prevention of CMV Infection
Paltiel et al.
Med Decis Making 1998;18:S93-S105.
ABSTRACT  

Cost-effectiveness of HIV Screening in Acute Care Settings
Owens et al.
Arch Intern Med 1996;156:394-404.
ABSTRACT  

Blood Transfusion and Blood Conservation: Cost and Utilization Issues
Goodnough et al.
American Journal of Medical Quality 1994;9:172-183.
ABSTRACT  

Safety and Cost-effectiveness of Solvent-Detergent--Treated Plasma: In Search of a Zero-Risk Blood Supply
AuBuchon and Birkmeyer
JAMA 1994;272:1210-1214.
ABSTRACT  

Urgency of Medical Care: Contrasting Perceptions of HIV-Positive Patients and Physicians
Zell and Goodman
Arch Intern Med 1994;154:1857-1862.
ABSTRACT  

Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Cost-benefit Analysis
Brandeau et al.
Arch Intern Med 1992;152:2229-2237.
ABSTRACT  

Comparisons of Hospital Care for Patients With AIDS and Other HIV-Related Conditions
Andrulis et al.
JAMA 1992;267:2482-2486.
ABSTRACT  

HIV Antibody Testing in Young, Urban Adults
Berrios et al.
Arch Intern Med 1992;152:397-402.
ABSTRACT  

CD4 Lymphocyte Concentrations in Patients With Newly Identified HIV Infection Attending STD Clinics: Potential Impact on Publicly Funded Health Care Resources
Hutchinson et al.
JAMA 1991;266:253-256.
ABSTRACT  

Prevalence of HIV Infection in Childbearing Women in the United States: Surveillance Using Newborn Blood Samples
Gwinn et al.
JAMA 1991;265:1704-1708.
ABSTRACT  

The 'Medicaidization' of AIDS: Trends in the Financing of HIV-Related Medical Care
Green and Arno
JAMA 1990;264:1261-1266.
ABSTRACT  

Developing AIDS Counselling Services: Problems and Problem-Solving
Bor and Miller
The Journal of the Royal Society for the Promotion of Health 1990;110:126-129.
ABSTRACT  

Preventive Medicine
Dandoy
JAMA 1990;263:2674-2675.
ABSTRACT  

The Costs of HIV Infections
Cheung and Sacks
JAMA 1990;263:1067-1067.
ABSTRACT  

The Costs of HIV Infections
Harris
JAMA 1990;263:1067-1068.
ABSTRACT  

The management of the AIDS crisis in the workplace: a survey of employers in New York City
Mitchell
Organization Environment 1990;4:63-74.
ABSTRACT  

Targeting AIDS Prevention and Treatment Toward HIV-1--Infected Persons: The Concept of Early Intervention
Francis et al.
JAMA 1989;262:2572-2576.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.